REDX — Redx Pharma Share News
0.000.00%
Last trade - 00:00- £35.01m
- £34.60m
- £4.20m
Redx Presenting at AFDD meeting
Redx to Present RXC004 Phase 1 Combination Data
Redx to Present Poster at ASN Kidney Week
Brief: Redx Pharma Says First Patient Dosed In Phase 2a Trial For RXC007
First Patient Dosed in Phase 2a Trial for RXC007
Brief: Redx Pharma Presents Rxc007 Pre Clinical And Phase 1 Data
Redx Presents RXC007 Preclinical and Phase 1 Data
Redx to Present Poster on RXC007 at ICLAF
TR-1: Notification of major holdings
Redx to Present at the ERS International Congress
Completion of Placing and Director/PDMR Dealings
Brief: Redx Pharma Announces Placing Of Shares Via Accelerated Bookbuild
Proposed Secondary Placing of Shares via ABB
AIM - AIM Notice - 27/07/2022
Exercise of Options, PDMR Dealing and TVR
Redx to Present at Virtual Investor Forum
Encouraging Data on Porcupine and ROCK Inhibitors
Interim Results for the Six Months Ended 31 March
Redx to Present at the ECM Congress